Brii BioSciences, that will have the goal of developing new medicines exclusively for the Chinese market. "The company I am trying to build is only going to do China," says Brii Chief Executive Zhi Hong. "I will not have any other market."
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2018/05/24/venture-capitalists-put-260-million-into-new-chinese-biotech/
via IFTTT
No comments:
Post a Comment